Breaking News
December 16, 2018 - ‘Easy Way Out’? Stigma May Keep Many From Weight Loss Surgery
December 16, 2018 - Gout drug may protect against chronic kidney disease
December 16, 2018 - Talking about memories enhances the wellbeing of older and younger people
December 16, 2018 - Occupational exposure to pesticides increases risk for cardiovascular disease among Latinos
December 16, 2018 - A biomarker in the brain’s circulation system may be Alzheimer’s earliest warning
December 16, 2018 - Magnesium may play important role in optimizing vitamin D levels, study shows
December 16, 2018 - The effect of probiotics on intestinal flora of premature babies
December 16, 2018 - Parents spend more time talking with kids about mechanics of using mobile devices
December 16, 2018 - Biohaven Announces Positive Results from Ongoing Rimegepant Long-Term Safety Study
December 16, 2018 - Arterial stiffness may predict dementia risk
December 16, 2018 - Study explores link between work stress and increased cancer risk
December 16, 2018 - Sex work criminalization linked to incidences of violence finds study
December 16, 2018 - Johns Hopkins researchers discover swarming behavior in fish-dwelling parasite
December 16, 2018 - Schistosomiasis prevention and treatment could help control HIV
December 16, 2018 - Early postpartum opioids linked with persistent usage
December 16, 2018 - Johns Hopkins researchers identify molecular causes of necrotizing enterocolitis in preemies
December 16, 2018 - Advanced illumination expands capabilities of light-sheet microscopy
December 16, 2018 - Alzheimer’s could possibly be spread via contaminated neurosurgery
December 16, 2018 - Unraveling the complexity of cancer biology can prompt new avenues for drug development
December 16, 2018 - Inflammatory Bowel Disease, Prostate Cancer Linked
December 16, 2018 - Cannabis youth prevention strategy should target mental wellbeing
December 15, 2018 - Recent developments and challenges in hMAT inhibitors
December 15, 2018 - Sewage bacteria found lurking in Hudson River sediments
December 15, 2018 - CDC selects UMass Amherst biostatistician model that helps predict influenza outbreaks
December 15, 2018 - Researchers reveal brain mechanism that drives itch-evoked scratching behavior
December 15, 2018 - New computer model helps predict course of the disease in prostate cancer patients
December 15, 2018 - Obesity to Blame for Almost 1 in 25 Cancers Worldwide
December 15, 2018 - How the brain tells you to scratch that itch
December 15, 2018 - New findings could help develop new immunotherapies against cancer
December 15, 2018 - World’s largest AI-powered medical research network launched by OWKIN
December 15, 2018 - Young people suffering chronic pain battle isolation and stigma as they struggle to forge their identities
December 15, 2018 - Lifespan extension at low temperatures depends on individual’s genes, study shows
December 15, 2018 - New ingestible capsule can be controlled using Bluetooth wireless technology
December 15, 2018 - Researchers uncover microRNAs involved in the control of social behavior
December 15, 2018 - Research offers hope for patients with serious bone marrow cancer
December 15, 2018 - Link between poverty and obesity is only about 30 years old, study shows
December 15, 2018 - Mass spectrometry throws light on old case of intentional heavy metal poisoning
December 15, 2018 - BeyondSpring Announces Phase 3 Study 105 of its Lead Asset Plinabulin for Chemotherapy-Induced Neutropenia Meets Primary Endpoint at Interim Analysis
December 15, 2018 - Study finds that in treating obesity, one size does not fit all
December 15, 2018 - Tenacity and flexibility help maintain psychological well-being, mobility in older people
December 15, 2018 - Study reveals role of brain mechanism in memory recall
December 15, 2018 - High levels of oxygen encourage the brain to remain in deep, restorative sleep
December 15, 2018 - Experimental HIV vaccine strategy works in non-human primates, research shows
December 15, 2018 - Genetically modified pigs could limit replication of classical swine fever virus, study shows
December 15, 2018 - FDA Approves Herzuma (trastuzumab-pkrb), a Biosimilar to Herceptin
December 15, 2018 - Cost and weight-loss potential matter most to bariatric surgery patients
December 15, 2018 - Cancer Research UK and AstraZeneca open new Functional Genomics Centre
December 15, 2018 - New research lays out potential path for treatment of Huntington’s disease
December 15, 2018 - Prestigious R&D 100 Award presented to Leica Microsystems
December 15, 2018 - Study shows septin proteins detect and kill gut pathogen, Shigella
December 15, 2018 - Study sheds new light on disease-spreading mosquitoes
December 15, 2018 - 2017 Saw Slowing in National Health Care Spending
December 15, 2018 - Monitoring movement reflects efficacy of mandibular splint
December 15, 2018 - Study supports BMI as useful tool for assessing obesity and health
December 15, 2018 - Self-guided, internet-based therapy platforms effectively reduce depression
December 15, 2018 - Organically farmed food has bigger climate impact than conventional food production
December 15, 2018 - Faster, cheaper test has potential to enhance prostate cancer evaluation
December 15, 2018 - Researchers study abnormal blood glucose levels of patients after hospital discharge
December 15, 2018 - Swedish scientists explore direct association of dementia and ischemic stroke deaths
December 15, 2018 - Study finds 117% increase in number of dementia sufferers in 26 years
December 15, 2018 - Eczema Can Drive People to Thoughts of Suicide: Study
December 15, 2018 - Link between neonatal vitamin D deficiency and schizophrenia confirmed
December 15, 2018 - Nurse denied life insurance because she carries naloxone
December 15, 2018 - Ritalin drug affects organization of pathways that build brain networks used in attention, learning
December 15, 2018 - Research pinpoints two proteins involved in creation of stem cells
December 15, 2018 - Gut bacteria may modify effectiveness of anti-diabetes drugs
December 15, 2018 - A new type of ‘painless’ adhesive for biomedical applications
December 15, 2018 - Early physical therapy associated with reduction in opioid use
December 15, 2018 - Breast cancer protection from pregnancy begins many decades later, study finds
December 15, 2018 - How often pregnant women follow food avoidance strategy to prevent allergy in offspring?
December 15, 2018 - Using machine learning to predict risk of developing life-threatening infections
December 15, 2018 - How imaginary friends could boost children’s development
December 15, 2018 - Folate deficiency creates more damaging chromosomal abnormalities than previously known
December 15, 2018 - Study provides new insights into molecular mechanisms underlying role of amyloid in Alzheimer’s disease
December 15, 2018 - For the asking, a check is in the mail to help pay for costly drugs
December 15, 2018 - UA scientists uncover biological processes leading to rare brain disorder in babies
December 15, 2018 - The largest database on industrial poisons
December 15, 2018 - ESMO Immuno-Oncology Congress showcases novel technologies set to benefit many cancer patients
December 15, 2018 - Ovid Therapeutics Announces Plans to Move into a Phase 3 Trial in Pediatric Patients Based on End-of-Phase 2 Meeting for OV101 in Angelman Syndrome
December 15, 2018 - Left ventricular noncompaction – Genetics Home Reference
A Patient’s Journey: And Now, a Word from a Pathologist

A Patient’s Journey: And Now, a Word from a Pathologist

image_pdfDownload PDFimage_print

I recently ran across a wide-ranging blog, “Getting More From Les,” written by suburban Chicago pathologist Lester Raff, MD.

I was amused by his tongue-in-cheek take on pathologists like him “giving (prostate) cancer” to patients. Actually, giving them prostate cancer diagnoses.

I wrote a fan note to Raff and told him there was another prostate cancer blogger in town. We started an email exchange, which I will share shortly.

We look at the pathology slide from different vantage points. Me with a Gleason 6 diagnosed by a pathologist like him. He as the expert using the art and science of pathology to diagnose cancer as lab director for UroPartners, a large urology group in the Chicago area. (He stresses in his blog and in his conversation with me that he is expressing his own opinions, not those of UroPartners.)

It turns out we had more in common. When he graduated from eighth grade, he had his eye on journalism. He wanted to attend the highly regarded Medill School of Journalism where, as it happens, I have taught in the grad school over the past 10 years.

But he took a radical turn and became a pathologist. Medicine’s gain has been journalism’s loss, though Les keeps a hand in journalism through his blog.

I had some questions from the patient point of view and solicited others from patient advocates Mike Scott, founder of Prostate Cancer International and Rick Davis, founder of Answer Cancer Foundation.

Here is my Q & A with Raff.

Wolinsky: “Do you often speak with men to whom you ‘give’ prostate cancer.”

Raff: “It is very interesting to me to see your perspective. As a pathologist I rarely talk with patients, other than friends and relatives whose biopsies I often wind up reading. I would enjoy talking with more patients, but only a few ever give me a call, even though my name and phone number are on our reports.

When I speak with patients, I try to restrict myself to the diagnosis of the prostate cancer and to the prognostic markers that can be obtained from the biopsy specimen.

I do not claim to be an expert on the varying, and expanding, armamentarium of treatments now available.”

Wolinsky: “It is my experience that many physicians refuse to have PSA screening because they see little value in it. What do you think about the value of PSAs?”

Raff: “I do believe in PSA screening and the use of prostate biopsies. On a personal level, I lost my dad to prostate cancer, and on a professional level I have seen a real (though anecdotal — I don’t have a full data analysis) increase in high-grade prostate cancer since the decline of PSA testing. I realize PSA testing grabs a lot of men (such as you) in its net that may not need therapy, but it also finds the men who have potentially aggressive disease and will benefit from earlier therapy.”

Wolinsky: “In the same vein, many men in active surveillance programs are rebelling against biopsies because they think they can rely on multi-parameter MRIs. (My urologist, Brian Helfand, MD, PhD, is not one. He sees biopsies as essential for active surveillance, the ‘gold standard.’). What do you think?”

Raff: “My experience with MRI at this time is that it is sub-optimal, with many false positives. I cannot speak to the false negative rate — if the men don’t get biopsied, I have no way of knowing whether or not disease is present.”

Wolinsky: “We know that different pathologists may grade slides differently … but what do you do to optimize the chances that you are ‘right’ as often as possible? For example, if you have a sense of difficulty in deciding whether a particular patient has Gleason 3 + 4 or 4 + 3, can you and do you have a colleague take a look at that particular set of slides too, to get a second ‘in-house’ opinion before a report is written up? Should that be noted in the pathology report when it happens?”

Raff: “In my institution, ALL malignant cases are reviewed at a daily quality assurance committee review at a video microscope. We frequently discuss the appropriate grade on a particular slide. All our reports document that a QA review occurred. I also track the opinions of other labs when our slides are sent to other institutions for second opinion, to see if we have any institutional bias toward up or down grading.”

Wolinsky: “Have there been technological improvements in the way prostate cancer pathology is carried out that have improved the ability to ‘see’ critical histopathological information?”

Raff: “There have not been significant changes in diagnostic techniques. There have been changes in patient safety in regards to proper identification of biopsies. We initiated and published an inking technique, and DNA patient identity testing (Know Error) has been embraced by many labs.

The other significant change is in the use of molecular diagnostics for prognostic markers in prostate cancer, as well as to try to identify patients with negative biopsies who may still be at significant risk for prostate cancer.”

Wolinsky: “What do you think about the change in the ways that the pathological findings should be reported: from Gleason patterns and Gleason scores to the new ISUP (International Society of Urological Pathology) scoring system?”

Raff: “These are cosmetic changes. All are still based on pattern recognition by the diagnosing pathologist, who in turn is dependent on receiving slides from properly obtained, processed, sectioned, and stained tissue.”

Wolinsky: “Considering just prostate specimens, what would you say are the most challenging aspects of your work?”

Raff: “It takes skill to translate a two-dimensional appearance to a three-dimensional structure, ignore distractions on the slide and in the laboratory, and to recognize mimics of cancer as well as very bland appearing malignancy.”

Wolinsky: “Why is there significant variation in how different laboratories report pathological data from biopsies? Shouldn’t there be a single standard format for reporting the key data?”

Raff: “Synoptic reporting, which meets your requirements, is required for most malignant specimens. However, it is NOT mandated for prostate biopsies, leaving each lab with freedom to include those elements they see fit, with some resultant anarchy. I believe this will change over the next few years.”

2018-03-01T00:00:00-0500

last updated

Tagged with:

About author

Related Articles